Renato Pasquali

Renato Pasquali's AcademicInfluence.com Rankings

Renato Pasquali

Biology

#9211

World Rank

#12387

Historical Rank

Endocrinology

#113

World Rank

#124

Historical Rank

biology Degrees

Download Badge

Biology

Renato Pasquali's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Renato Pasquali Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Renato Pasquali's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline (2013) (1326)
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. (2003) (1173)
The emerging role of the endocannabinoid system in endocrine regulation and energy balance. (2006) (825)
Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. (1998) (782)
Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. (2006) (652)
Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. (2000) (580)
Obesity and reproductive disorders in women. (2003) (481)
Obesity and the polycystic ovary syndrome (2002) (479)
Consensus on infertility treatment related to polycystic ovary syndrome (2008) (448)
Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. (1989) (420)
Obesity and androgens: facts and perspectives. (2006) (407)
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. (2005) (403)
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. (2009) (388)
The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. (1993) (375)
Obesity and infertility (2007) (353)
Effect of obesity and body fat distribution on sex hormones and insulin in men. (1991) (350)
Endogenous cannabinoid system as a modulator of food intake (2003) (316)
The Hypothalamic‐Pituitary‐Adrenal Axis Activity in Obesity and the Metabolic Syndrome (2006) (307)
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. (2014) (307)
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. (2014) (266)
Review article: The impact of obesity on reproduction in women with polycystic ovary syndrome (2006) (265)
The role of low-grade inflammation in the polycystic ovary syndrome (2011) (231)
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome (2004) (227)
The impact of obesity on reproduction in women with polycystic ovary syndrome. (2006) (226)
Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. (1995) (225)
The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women * (1993) (213)
Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. (2007) (213)
Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. (2002) (209)
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. (2006) (206)
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. (2010) (189)
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors. (2004) (179)
PCOS Forum: research in polycystic ovary syndrome today and tomorrow (2011) (161)
Serum steroid profiling by isotopic dilution-liquid chromatography–mass spectrometry: Comparison with current immunoassays and reference intervals in healthy adults (2011) (161)
The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long‐term oestrogen–progestagen treatment (1999) (155)
Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. (2000) (151)
Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. (2013) (148)
Metabolic effects of obesity on reproduction. (2006) (147)
Cannabinoid Type 1 Receptor Blockade Promotes Mitochondrial Biogenesis Through Endothelial Nitric Oxide Synthase Expression in White Adipocytes (2008) (145)
Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome. (1997) (137)
Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Group. (1994) (137)
Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. (2002) (136)
Glucocorticoids and Type 2 Diabetes: From Physiology to Pathology (2012) (136)
Activity of the hypothalamic–pituitary–adrenal axis in different obesity phenotypes (2000) (135)
Stress‐related Development of Obesity and Cortisol in Women (2009) (134)
Obesity, fat distribution and infertility. (2006) (134)
Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes (2012) (129)
Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group. (1997) (129)
Testosterone replacement therapy restores normal ghrelin in hypogonadal men. (2003) (128)
Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome. (1994) (120)
The Endocannabinoid System and Energy Metabolism (2008) (116)
Gastric emptying of solids in morbid obesity. (1996) (112)
Testosterone levels in obese male patients with obstructive sleep apnea syndrome: Relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters (2003) (110)
Subclinical hypercortisolism: a state, a syndrome, or a disease? (2015) (109)
The hypothalamic–pituitary–adrenal axis and sex hormones in chronic stress and obesity: pathophysiological and clinical aspects (2012) (106)
Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology (2014) (106)
Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. (1996) (106)
Body mass index-independent metabolic alterations in narcolepsy with cataplexy. (2009) (106)
Polycystic Ovary Syndrome (2006) (105)
Transient hypoparathyroidism following thyroidectomy: A prospective study and multivariate analysis of 604 consecutive patients (2007) (100)
Clomiphene citrate, metformin or both as first‐step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head‐to‐head randomized controlled studies and meta‐analysis (2009) (95)
Insulin-sensitizing agents in polycystic ovary syndrome. (1998) (95)
Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels. (1983) (94)
[Pharmacological therapy of obesity]. (2008) (91)
Circulating obestatin levels and the ghrelin/obestatin ratio in obese women. (2007) (91)
Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome (2003) (89)
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study. (2014) (89)
Energy balance regulation by endocannabinoids at central and peripheral levels. (2011) (88)
Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome. (2011) (86)
The endocannabinoid system and the treatment of obesity (2005) (85)
Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries (1986) (85)
Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective. (2016) (83)
Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism. (1993) (83)
Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal-weight men. (1997) (83)
ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome (1999) (81)
European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire. (2014) (80)
Genetic variation in 11β-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome (2006) (79)
Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS (2012) (75)
Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors (2005) (75)
Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. (2012) (73)
Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes Results From a Long-Term Prospective Study (2012) (72)
Dietary habits and their relationship with hormones and metabolism in overweight and obese women with polycystic ovary syndrome (2013) (72)
Comment: response of the hypothalamic-pituitary-adrenocortical axis to high-protein/fat and high-carbohydrate meals in women with different obesity phenotypes. (2002) (72)
Cannabinoid Type 1 Receptor: Another Arrow in the Adipocytes’ Bow (2008) (70)
Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity (2008) (69)
Treatment of obese patients with obstructive sleep apnea syndrome (OSAS): effect of weight loss and interference of otorhinolaryngoiatric pathology. (1990) (66)
Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution (1998) (63)
European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity. (2020) (62)
Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. (2003) (62)
Influence of menopause on blood cholesterol levels in women: the role of body composition, fat distribution and hormonal milieu (1997) (62)
Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels. (1998) (60)
MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview. (2017) (59)
Insulin and C-peptide levels in obese patients with polycystic ovaries. (1982) (59)
Type 2 diabetes and the polycystic ovary syndrome. (2004) (57)
Steroid Profiling by LC-MS/MS in Nonsecreting and Subclinical Cortisol-Secreting Adrenocortical Adenomas. (2015) (57)
Glucose intolerance states in women with the polycystic ovary syndrome (2013) (56)
Characterization of obese women with reduced sex hormone-binding globulin concentrations. (1990) (55)
A controlled trial using ephedrine in the treatment of obesity. (1985) (55)
Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome. (2009) (54)
Sex Difference in the Relationship between the Hypothalamic‐pituitary‐adrenal Axis and Sex Hormones in Obesity (2006) (54)
Role of sex hormones in modulation of brown adipose tissue activity. (2012) (53)
Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome. (2010) (53)
The abdominal obesity phenotype and insulin resistance are associated with abnormalities of the hypothalamic-pituitary-adrenal axis in humans. (2000) (53)
Androgen profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in healthy normal-weight ovulatory and anovulatory late adolescent and young women. (2013) (52)
Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. (2010) (51)
A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome. (2011) (51)
Endocrine dysfunction in hereditary hemochromatosis (2016) (50)
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases. (2006) (50)
Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin. (2008) (49)
Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review (2016) (48)
The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women (1991) (47)
Centenarians’ offspring as a model of healthy aging: a reappraisal of the data on Italian subjects and a comprehensive overview (2016) (47)
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. (2007) (45)
New perspectives on the definition and management of polycystic ovary syndrome (2018) (45)
Assessment of nutritional status in Crohn's disease in remission or low activity. (1984) (44)
Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women. (2012) (43)
Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. (2007) (42)
Adrenal and gonadal function in obesity (2002) (42)
Prevalence of hyperandrogenic states in late adolescent and young women: epidemiological survey on italian high-school students. (2013) (42)
Gastric immunolocalization and plasma profiles of acyl-ghrelin in fasted and fasted-refed prepuberal gilts. (2005) (41)
Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome. (2014) (41)
How many sites of action for endocannabinoids to control energy metabolism? (2006) (40)
Weight loss and sex steroid metabolism in massively obese man (1988) (40)
Tubercular Involvement of the Thyroid Gland: A Report of Two Cases (2000) (40)
Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. (2012) (39)
Role of changes in dietary habits in polycystic ovary syndrome. (2004) (38)
Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome. (2005) (37)
Achievement of near-normal body weight as the prerequisite to normalize sex hormone-binding globulin concentrations in massively obese men (1997) (37)
Ghrelin and reproductive disorders (2011) (37)
Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects. (1992) (36)
Cortisol, energy intake, and food frequency in overweight/obese women. (2011) (36)
Targeting insulin sensitivity in the treatment of polycystic ovary syndrome (2009) (35)
Obesity and Androgens in Women. (2019) (35)
Validation of an LC–MS/MS salivary assay for glucocorticoid status assessment: Evaluation of the diurnal fluctuation of cortisol and cortisone and of their association within and between serum and saliva (2016) (35)
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis (2007) (34)
Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease (1986) (33)
Acyl ghrelin and metabolic hormones in pregnant and lactating sows. (2007) (33)
Antagonizing the cannabinoid receptor Type 1: A dual way to fight obesity (2003) (33)
Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution (2012) (32)
Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis. (2020) (32)
Functional effects of polymorphisms in the human gene encoding 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1): a sequence variant at the translation start of 11 beta-HSD1 alters enzyme levels. (2010) (31)
Psychological aspects of hyperandrogenic states in late adolescent and young women (2015) (29)
Clomiphene citrate effect in obese men with low serum testosterone treated with metformin due to dysmetabolic disorders: A randomized, double-blind, placebo-controlled study (2017) (29)
Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome (2012) (29)
Testosterone therapy in men: Clinical and pharmacological perspectives (2000) (29)
Polycystic Ovary Syndrome in Adolescents (2003) (28)
Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism (2018) (28)
The potential role of increased adrenal volume in the pathophysiology of obesity-related Type 2 diabetes (2006) (28)
Increased clearance of cortisol by 5β-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome (2009) (27)
Contemporary approaches to the management of polycystic ovary syndrome (2018) (27)
Heterogeneity of Thyroid Function and Impact of Peripheral Thyroxine Deiodination in Centenarians and Semi-Supercentenarians: Association With Functional Status and Mortality. (2018) (27)
Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. (2006) (27)
Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women (2017) (26)
Interrelationships between body weight, body fat distribution and insulin in obese women before and after hypocaloric feeding and weight loss. (1989) (26)
High serum concentration of total inhibin in polycystic ovary syndrome. (2008) (26)
Revisiting hyper- and hypo-androgenism by tandem mass spectrometry (2013) (26)
Active and Total Ghrelin Concentrations in the Newborn (2005) (25)
Obesity and Hormonal Abnormalities (2002) (25)
The unrelenting fall of the pharmacological treatment of obesity (2013) (25)
The role of the opioid peptides in the development of hyperinsulinemia in obese women with abdominal body fat distribution. (1992) (24)
Leptin and the hypothalamic-pituitary-adrenal axis activity in women with different obesity phenotypes (1997) (24)
Seasonal variations of total and free thyroid hormones in healthy men: a chronobiological study. (1984) (24)
Sex hormones in obese premenopausal women and their relationships to body fat mass and distribution, B cell function and diet composition (1987) (23)
Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls. (2014) (23)
MANAGEMENT OF ENDOCRINE DISEASE: Secondary polycystic ovary syndrome: theoretical and practical aspects. (2016) (23)
(11)C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-to-brown fat conversion. (2013) (22)
Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes (2015) (22)
Tablet and oral liquid L-thyroxine formulation in the treatment of naïve hypothyroid patients with Helicobacter pylori infection (2017) (22)
Parallel diurnal fluctuation of testosterone, androstenedione, dehydroepiandrosterone and 17OHprogesterone as assessed in serum and saliva: validation of a novel liquid chromatography-tandem mass spectrometry method for salivary steroid profiling (2017) (22)
Treatment of the polycystic ovary syndrome with lifestyle intervention (2002) (22)
The steroid profile of adrenal incidentalomas: subtyping subjects with high cardiovascular risk. (2019) (22)
Human chorionic gonadotropin stimulation gives evidence of differences in testicular steroidogenesis in Klinefelter syndrome, as assessed by liquid chromatography-tandem mass spectrometry. (2016) (22)
Protein metabolism in obese patients during very low-calorie mixed diets containing different amounts of proteins and carbohydrates. (1987) (21)
α2‐adrenoceptor regulation of the hypothalamic‐pituitary‐adrenocortical axis in obesity (2000) (21)
Peripheral Endocannabinoid System‐Mediated Actions of Rimonabant on Growth Hormone Secretion are Ghrelin‐Dependent (2010) (21)
EFFECT OF PROLONGED ADMINISTRATION OF RANITIDINE ON PITUITARY AND THYROID HORMONES, AND THEIR RESPONSE TO SPECIFIC HYPOTHALAMIC‐RELEASING FACTORS (1981) (21)
Cross-talk between adipose tissue and the HPA axis in obesity and overt hypercortisolemic states (2014) (21)
Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern. (2013) (20)
Does ephedrine promote weight loss in low-energy-adapted obese women? (1987) (20)
Clinical aspects of ephedrine in the treatment of obesity. (1993) (20)
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy (2018) (20)
Mechanisms of action of the intragastric balloon in obesity: Effects on hunger and satiety (1990) (20)
[Influence of weight and distribution of adipose tissue in functional hyperandrogenism]. (1998) (20)
Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome (2011) (20)
Endocannabinoids and energy metabolism. (2006) (18)
Insulin-sensitizing agents in women with polycystic ovary syndrome. (2006) (18)
Predictors of weight loss and maintenance in patients treated with antiobesity drugs (2011) (18)
Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries (1987) (18)
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men (2005) (18)
No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen‐secreting tumours (2013) (18)
Insulin sensitizers in polycystic ovary syndrome. (2013) (18)
New insights on diabetes in Turner syndrome: results from an observational study in adulthood (2018) (17)
Here, There and Everywhere: the Endocannabinoid System (2008) (17)
94276347 Body weight, fat distribution and the menopausal status in women (1995) (17)
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma (2018) (17)
Obesity-related proliferative diseases: the interaction between adipose tissue and estrogens in post-menopausal women (2015) (16)
Can Imaging Predict Subclinical Cortisol Secretion in Patients With Adrenal Adenomas? A CT Predictive Score. (2017) (16)
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology (2015) (16)
Metabolic Syndrome in Polycystic Ovary Syndrome. (2018) (15)
The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease. (2005) (15)
Steroids and the metabolic syndrome (2008) (15)
Aldosterone and type 2 diabetes mellitus (2016) (15)
EFFECT OF ‘PHYSIOLOGICAL’ DOSES OF TRIIODOTHYRONINE REPLACEMENT ON THE HORMONAL AND METABOLIC ADAPTATION TO SHORT‐TERM SEMISTARVATION AND TO LOW‐CALORIE DIET IN OBESE PATIENTS (1984) (14)
The endocannabinoid system in the regulation of cardiometabolic risk factors. (2007) (14)
Relationship between socio-economic and cultural status, psychological factors and body fat distribution in middle-aged women living in Northern Italy (2001) (14)
Heterogeneity of the erythrocyte Na-K pump status in human obesity. (1985) (14)
Androgens in Congenital Adrenal Hyperplasia. (2019) (14)
The Biological Balance between Psychological Well-Being and Distress: A Clinician’s Point of View (2006) (13)
Combined Aldosterone and Cortisol Secretion by Adrenal Incidentaloma (2012) (13)
Glucose tolerance, insulin secretion and insulin sensitivity in polycystic ovary syndrome. (2002) (13)
Acute severe male hypo-testosteronemia affects central motor command in humans. (2016) (13)
Beta-endorphin response to exogenous corticotrophin-releasing hormone in obese women with different patterns of body fat distribution. (1993) (13)
Effect of dietary carbohydrates during hypocaloric treatment of obesity on peripheral thyroid hormone metabolism (1982) (13)
Effect of small doses of dexamethasone on plasma leptin levels in normal and obese subjects: A dose-response study (2003) (13)
Abdominal adiposity by ultrasonography: a "pocket" database for reference standard in Italian people. (2014) (12)
Secretion of major adrenal androgens following ACTH administration in obese women with different body fat distribution. (1998) (12)
Cortisol and the polycystic ovary syndrome (2012) (12)
Is the hypothalamic-pituitary-adrenal axis really hyperactivated in visceral obesity? (1998) (12)
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report. (2011) (12)
Prescription Medications for the Treatment of Obesity (2015) (12)
Metabolic alterations and cardiovascular risk factors in the polycystic ovary syndrome. (2005) (12)
Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone (2020) (11)
Resting Energy Expenditure, Thermic Eﬀect of Food, and Total Energy Expenditure (2003) (11)
Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome (2006) (11)
Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity (2004) (10)
Cannabinoid receptor antagonists and the metabolic syndrome: Novel promising therapeutical approaches. (2007) (10)
The Significance of Low Testosterone Levels in Obese Men (2012) (10)
Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation (2019) (10)
Nitrendipine treatment in women with polycystic ovarian syndrome: evidence for a lack of effects of calcium channel blockers on insulin, androgens, and sex hormone-binding globulin. (1995) (9)
In vivo dissolution of levothyroxine soft gel capsules (2016) (9)
Glucocorticoids, stress and obesity (2010) (9)
Hormones and pathophysiology of obesity. (2001) (9)
Serum Vitamin D Binding Protein Level Associated with Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome (2018) (9)
A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome (2015) (9)
Thermogenic agents in the treatment of human obesity: preliminary results. (1987) (9)
[Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?]. (1996) (8)
Epidemiology of obesity in the elderly: CNR multicentric study in Italy. (1990) (8)
Insulin sensitizing agents and polycystic ovary syndrome. (1998) (8)
Body fat distribution and weight loss in obese women. (1989) (8)
Secondary polycystic ovary syndrome: theoretical and practical aspects (2016) (7)
A combination of polymorphisms in HSD 11 B 1 associates with in vivo 11 b-HSD 1 activity and metabolic syndrome in women with and without polycystic ovary syndrome (2011) (7)
Behavioral, socio-environmental, educational and demographic correlates of excess body weight in Italian adolescents and young adults. (2019) (7)
Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through eNOS expression in white adipocytes (2008) (7)
The Endocannabinoid System in the Physiopathology of Metabolic Disorders (2007) (7)
The steroid response to human chorionic gonadotropin (hCG) stimulation in men with Klinefelter syndrome does not change using immunoassay or mass spectrometry (2017) (7)
Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal. (1987) (7)
Erratum to: Metformin in women with PCOS, Pros (2015) (7)
The empowerment of translational research: lessons from laminopathies (2012) (7)
Relationships between total and regional adiposity and epicardial fat in obese women: how can dual‐energy X‐ray absorptiometry be associated with echocardiographic epicardial fat measurements? (2013) (7)
Erythrocyte Na-K-ATPase membrane activity in obese patients fed over a long-term period with a very-low-calorie diet. (1988) (7)
Effect of clomiphene citrate treatment on the Sertoli cells of dysmetabolic obese men with low testosterone levels (2020) (6)
Insights into tandem mass spectrometry for the laboratory endocrinology (2013) (6)
Effects of short- and long-term administrations of famotidine and ranitidine on some pituitary, sexual and thyroid hormones. (1987) (6)
A placebo-controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effect on anthropometric, metabolic and biochemical parameters. (2011) (6)
Relationships between iodothyronine peripheral metabolism and ketone bodies during hypocaloric dietary manipulations (1983) (6)
Altered erythrocyte Na-K pump in anorectic patients. (1985) (6)
Salivary cortisol and cortisone responses to short-term psychological stress challenge in late adolescent and young women with different hyperandrogenic states (2018) (5)
Branched-Chain Amino Acid Database Integrated in MEDIPAD Software as a Tool for Nutritional Investigation of Mediterranean Populations (2018) (5)
Quality of diet, screened by the Mediterranean diet quality index and the evaluation of the content of advanced glycation endproducts, in a population of high school students from Emilia Romagna (2010) (5)
Anthropometric, hormonal and nutritional correlates of epicardial fat in obese women (2012) (5)
Double blind controlled trial with oxmetidine and cimetidine in the short-term treatment of duodenal ulcer. (1981) (5)
Feeding disorders and obesity. (2009) (5)
[Obesity and adipose tissue distribution in men: relation to sex steroids and insulin]. (1991) (5)
The Endocrine Impact of Obesity and Body Habitus in the Polycystic Ovary Syndrome (2006) (5)
Consensus on infertility treatment related to polycystic ovary syndrome (Human Reproduction (2007) 23, (462)) (2008) (5)
Adrenomedullary Hyperplasia in a Patient with Poorly Controlled Hypertension andNeurofibromatosis Type 1: A Case Report (2016) (4)
Erythrocyte Na+-ATPase in obese patients. (1984) (4)
Treatment of hirsutism in the polycystic ovary syndrome (2014) (4)
Benfluorex action on metabolic control and insulin sensitivity in type 2 non-insulin dependent diabetics. (1989) (4)
Epidemiological survey on the prevalence of hyperandrogenic states in adolescent and young women (2012) (4)
COMBINED EFFECTS OF PROBUCOL AND CHOLESTYRAMINE IN FAMILIAL TYPE II HYPERLIPOPROTEINAEMIA (1981) (4)
Role of Obesity and Adiposity in PCOS (2007) (4)
Improving the diagnosis of 11β-hydroxylase deficiency using home-made MLPA probes: identification of a novel chimeric CYP11B2/CYP11B1 gene in a Sicilian patient (2016) (4)
Testosterone in ageing men (2001) (4)
Hyperandrogenism, hyperinsulinism and polycystic ovarian disease (1986) (3)
Evidence for a physiological reduction in brain dopamine but not norepinephrine metabolism during the preovulatory phase in normal women. (1987) (3)
Mechanisms and Treatment of Obesity in Polycystic Ovary Syndrome (2008) (3)
[Pseudo-Cushing syndrome. Physiopathologic aspects and differential diagnosis]. (2000) (3)
Sex hormones and the development of type 2 diabetes in women (2017) (3)
Anti-müllerian hormone and insulin-like 3 levels in healthy normal-weight ovulatory and anovulatory eumenorrheic late adolescent females: potential early biomarkers of ovarian dysfunction? (2015) (3)
Effect of acute oral and intravenous administration of ranitidine on prolactin, thyrotropin and gonadotropin serum levels. (1982) (3)
The polycystic ovary syndrome: a position statement from the European Society of (2014) (3)
Insulin Resistance: Definition and Epidemiology in Normal Women and Polycystic Ovary Syndrome Women (2007) (3)
Changes in brain catecholamine metabolism during bromocriptine treatment in polycystic ovary syndrome. (1993) (2)
Isolated failure of noradrenergic transmission in a case with orthostatic hypotension and hyperactivity of gastro-colic reflex (1992) (2)
New perspectives on the role of anti-Müllerian hormone (AMH) in women. (2018) (2)
Bisphenol A impacts hormonal profile in patients with polycystic ovary syndrome but not in healthy women (2020) (2)
Reproductive endocrinology: Maternal and fetal insulin levels at birth in women with PCOS (2014) (2)
Prevalence of Metabolic Syndrome in Organ Transplantation: A Review of the Literature (2015) (2)
21th European Congress on Obesity (ECO2014), Sofia, Bulgaria, May 28-31, 2014: Abstracts (2014) (2)
The role of the endocannabinoid pathway in metabolism and diabetes (2006) (2)
Cannabinoids in energy balance and prospectives in the therapy of obesity (2003) (2)
Lifestyle Interventions and Natural and Assisted Reproduction in Patients with PCOS (2018) (2)
Androgen profiling in adolescent females by liquid chromatography-tandem mass spectrometry (2012) (2)
Insulin Resistance and Polycystic Ovarian Syndrome (2007) (2)
Medical philately. Thyroid: from hellenistic Greece to renaissance. (2010) (2)
Effect of a caloric supplement in malnourished patients with Crohn's disease (1984) (2)
Ghrelin in non-alcoholic fatty liver disease (2003) (2)
Diabetes: From Ancient Egypt to the 18th Century. (2015) (1)
Weight loss determines a complete remission of the polycystic ovary syndrome in most of obese women (2008) (1)
Focus on novel developments of PCOS: conclusions from the PCOS Task Force: treatment of PCOS (2014) (1)
Chapter-45 Clomiphene citrate, Metformin or both for the treatment of anovulatory women with PCOS: evidence-based recommendations (2016) (1)
Sex hormone and steroid precursor measurement by simple and rapid liquid chromatography-tandem mass spectrometry (Lc-Ms/Ms) method: comparison with current routine immunoassays (2016) (1)
Metformin in women with PCOS, pros. (2015) (1)
Type 2 Diabetes in Polycystic Ovary Syndrome (2014) (1)
Medical philately. Diabetes: from ancient Egypt to the 18th century. (2010) (1)
Energy Homeostasis: Endocannabinoid System (2009) (1)
[Endocannabinoid system and energy metabolism: physiology and pathophysiology]. (2008) (1)
Simultaneous determination of salivary androgens by liquid chromatography-tandem mass spectrometry: analytical and biological validation (2014) (1)
FUNCTIONAL EFFECTS OF POLYMORPHISMS IN THE HUMAN GENE ENCODING 11β-HSD1: A SEQUENCE VARIANT AT THE TRANSLATION START OF 11β-HSD1 ALTERS ENZYME LEVELS (2014) (1)
Brite adipocytes: a role for cannabinoid receptor type 1 in brown adipose cell recruitment (2013) (1)
Circulating endocannabinoids are differentially modulated during the oral glucose tolerance test (2013) (1)
Adult Obesity: Fertility (2010) (1)
Prevalence of metabolic syndrome in a cohort of young Mediterranean women with polycystic ovary syndrome and association with clinical and biochemical parameters (2007) (1)
A New Interaction to Come: Ghrelin and Steroid Hormones (2004) (1)
Urinary excretion rate of C-peptide in fed and fasted obese humans. (1988) (1)
Chronic oral administration of lansoprazole does not affect the hypothalamic pituitary gonadal axis in healthy young men. (1995) (1)
Economy of Energy Expenditure and Body Composition after Weight Loss (1992) (1)
[Steroid therapy and adrenal function]. (2000) (1)
Functional Effects of Polymorphisms in the Human Gene Encoding 11 (cid:1) -Hydroxysteroid Dehydrogenase Type 1 (11 (cid:1) -HSD1): A Sequence Variant at the Translation Start of 11 (cid:1) -HSD1 Alters Enzyme Levels (2009) (1)
Comprar Insulin Resistance and Polycystic Ovarian Syndrome · Pathogenesis, Evaluation, and Treatment | Diamanti-Kandarakis, Evanthia | 9781588297631 | Springer (2007) (1)
Interrelationships between dietary carbohydrates, B cell function and rate of ketogenesis during underfeeding in obese patients. (1987) (1)
Medical philately. Endocrine international congresses. (2011) (0)
[Relationships between the number of adipocytes and age in the onset of obesity. Can the number of adipocytes increases in adult obesity?]. (1981) (0)
Adrenal Gland. (2015) (0)
DB111360 2369..2374 (2012) (0)
MODULATION OF BROWN ADIPOSE (2012) (0)
Endocannabinoid 2-arachidonoylglycerol plasma level is a BMI-independent biomarker of cardiometabolic risk in adult males with higher relevance in lean and aged conditions (2017) (0)
Insulin-Like Factor 3: a new circulating marker for the polycystic ovary syndrome-type of ovarian dysfunction (2006) (0)
HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION (2005) (0)
Higher cortisol response to glucose load in patient with adrenal adenomas and subclinical Cushing (SC) (2010) (0)
Diabetes: modern times. (2010) (0)
Aortic root dilatation in primary aldosteronism: is treatment effective in reducing aortic damage? (2018) (0)
[Hemorheologic and coagulation study in a group of patients with diabetic retinopathy]. (1984) (0)
Salivary cortisol response to psychological stress in late adolescent and young women: impact of menstrual irregularity, hirsutism, and hyperandrogenaemia (2015) (0)
Expression of the different components of the endocannabinoid system (ECs) in morbid obesity (2008) (0)
Specific neuronal deletion of cannabinoid type 1 receptor (CB1) mice exhibits reduced fat mass and diet-induced obesity resistance (2008) (0)
Basal INSL3 levels predict LH and androgen response to GnRH analogue in PCOS women (2008) (0)
Redefinition of age and sex specific reference intervals of eight serum steroids by liquid chromatography: tandem mass spectrometry (LC-MS/MS) (2011) (0)
Endocrinology and Art (2010) (0)
Adulthood follow-up of a large number of patients with congenital morphological alteration of anterior and/or posterior pituitary lobes (2007) (0)
[Effect of guar on plasma lipids and on the biological activity of insulin in patients with type 2 diabetes mellitus]. (1987) (0)
EFFECTS OF METFORMIN ON SPONTANEOUS AND CLOMIPHENE-INDUCED OVULATION IN THE POLYCYSTIC OVARY SYNDROME (1998) (0)
Endocrine effects of the H2-receptor antagonists cimetidine and ranitidine. (1983) (0)
Trials of dietary intervention and impact on key features in overweight / obese women with polycystic Study Patients Duration Intervention Weight loss (2009) (0)
[24-hour profile of intermediate metabolites in diabetic patients treated with human insulin (HM, Novo)]. (1984) (0)
Medical philately: genitalia and infertility. (2011) (0)
Effect of clomiphene citrate and metformin on testosterone levels in hypogonadal obese men with impaired glucose tolerance (IGT) or type 2 diabetes (DM2) (2016) (0)
The endocannabinoid system, energy expenditure and thermogenesis (2008) (0)
The Hermaphroditos Asleep (2011) (0)
Thyroid: From 16th to 20th Century. (2015) (0)
Occurrence of liver failure in post-surgery hypopituitaric patients (2015) (0)
Radiological formula for differentiating between secreting and non secreting adrenal adenomas (2016) (0)
Steroid profiling by liquid chromatography-tandem mass spectrometry in patients with non-secreting adrenocortical adenomas and subclinical hypercortisolism (2015) (0)
[The clofibrate-dipyridamole combination in the treatment of athero-arteriosclerotic vasculopathy]. (1979) (0)
Thyroid: from 16th to 20th century. (2010) (0)
Insulin action in brown adipose tissue is compromised during diet-induced obesity (2012) (0)
Reference interval values of four plasmatic endocannabinoids measured by isotopic dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS) (2010) (0)
The endocannabinoid action in the regulation of energy balance is mainly due to the CB1 receptor in the forebrain neurons (2010) (0)
[Ischemic injury of the pancreas by celiac artery stenosis]. (1980) (0)
The circulating fingerprint revealed by targeted metabolomic as biomarker of metabolic impairment in female overweight/obesity (2016) (0)
An exciting challenge for obesity research in Italy: The role of the Journal of Endocrinological Investigation (2009) (0)
Management of the metabolic syndrome and glucose intolerance in women with PCOS (2013) (0)
Diabetes : Modern Times. (2015) (0)
Application of Diagnostic Techniques to Endocrinology. (2015) (0)
Vasopressin and CTproAVP in pathogenetic conditions Diabetes insipidus (2014) (0)
Endocrine and metabolic alterations in narcoleptic patients as result of orexin-A reduction (2008) (0)
The diagnosis of PCOS in adults: new biomarkers (2013) (0)
Targeting insulin sensitivity in the treatment of PCOS (2009) (0)
Ascending aorta dilatation in primary aldosteronism: a new deleterious consequence of aldosterone excess (2016) (0)
Effect of glucose administration on thyroid hormones and oxygen consumption in normal and obese subjects. (1986) (0)
Daily and nightly urinary free cortisol ratio as a marker of the hypothalamic-pituitary-adrenal (HPA) axis activity in abdominal obesity (2008) (0)
Array-comparative genomic hybridization in congenital morphological alteration of the pituitary gland (2012) (0)
Medical philately. Adrenal gland. (2011) (0)
Cannabinoid receptor type 1 (CB1) affects hypothalamic-pituitary-adrenal (HPA) axis activity at cerebral and pituitary level (2003) (0)
Small animal PET/CT imaging reveals altered in vivo insulin function in brown adipose tissue of obese mice (2011) (0)
Prospects for a new assessment of polycystic ovarian syndrome (2017) (0)
Current Management of Polycystic Ovary Syndrome: Approaches to lifestyle management in polycystic ovary syndrome (2010) (0)
Subject Index Vol. 52, 1999 (2000) (0)
Individual pharmacological therapy for polycystic ovary syndrome: lessons from the phenotype (2007) (0)
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy (2018) (0)
Endocrinology and art. A dwarf at Epulone's supper - La cena del ricco Epulone - Luca Giordano. (2010) (0)
Medical philately (medical theme on stamps): obesity. (2011) (0)
Might cortisol modulate food choices in subclinical autonomous glucocorticoids hypersecretion (2014) (0)
Metabolic Consequences: Obesity and Energy Expenditure, Can They Be Treated? (2016) (0)
Haematic circulating endocannabinoids (ECs) in lean, overweight and obese: the role of the gender (2011) (0)
Disentangling polycystic ovary syndrome (PCOS) components by liquid-chromatography - tandem mass spectrometry (LC-MS/MS) steroid profiling (2018) (0)
Clinical relevance of 18F-FDG focal thyroid uptake as an incidental finding (2006) (0)
Epicardial fat assessed by dual-energy x-ray absorptiometry (2018) (0)
Medical philately. Application of diagnostic techniques to endocrinology. (2011) (0)
Genitalia and infertility. (2010) (0)
Strengths and Weaknesses of the Main Features of PCOS as Adapted from the NIH Evidence-Based Methodology Workshop on PCOS (2013) (0)
[Influence of obesity and maturity-onset diabetes on the kinetics of NEFA during oral glucose tolerance tests (OGTT)]. (1979) (0)
A simple and rapid method for steroid profiling by two dimensional liquid chromatography-tandem mass spectrometry: toward routine application (2015) (0)
Genitalia and Infertility. (2015) (0)
Effects of pharmacological stimulation or blockade of cannabinoid receptor type 1 (CB1) on gene expression in mouse cultured adipocyte cells (2007) (0)
[Relationship between thyroid hormones and body weight (TRH-induced thyrotropin secretion in female obesity]. (1978) (0)
Thermogenic and metabolic effects of etilefrine: acute and chronic studies in obese women (1987) (0)
Will steroid measurements affect the outcomes of clinical trials? Comparison between immunoassayand mass spectrometry in men with Kinefelter Syndrome undergoing human corionic gonadotropin stimulation test. (2016) (0)
Circulating endocannabinoids are associated with cardiometabolic impairment independently of adiposity in normal weight subjects (2014) (0)
Relationship among stress, weight gain and the activity of the hypothalamic-pituitary-adrenal (HPA) axis (2008) (0)
Hyperactivity of the hypothalamic-pituitary-axis and adrenal hyperandrogenism in polycystic ovary syndrome: a consequence of 5 β-reductase hyperfunction (2007) (0)
Front & Back Matter (2020) (0)
Clinical application of the 24-H urinary C-peptide excretion rate and its relationship to metabolic control in diabetics (1983) (0)
Genitalia and Infertility. (2015) (0)
Interrelationships between body weight, insulin secretion from B cell and metabolic control in type 2 (non-insulin-dependent) diabetics with fasting hyperglycemia. (1987) (0)
Subject Index Vol. 67, Suppl. 1, 2007 (2007) (0)
Monogenic form of polycystic ovary syndrome due to mutation in lamin A/C gene: case report of two sisters (2008) (0)
Contents, Vol. 39, 1993 (1993) (0)
Menopause is a major determinant of endocannabinoid 2-arachidonoylglycerol plasma level and of its relevance as biomarker of dyslipidemia and insulin resistance in lean women (2017) (0)
Circulating endocannabinoids are associated to cardiometabolic alterations independently from adiposity (2012) (0)
Insulin Resistance, Diabetes, and Cardiovascular Risk in Women and the Paradigm of the Polycystic Ovary Syndrome (2009) (0)
Medical philately. Application of diagnostic techniques to endocrinology. (2011) (0)
[Comparative effect of probucol and clofibrate in patients with primary hypercholesterolemia]. (1982) (0)
Endocrine International Congresses. (2015) (0)
Two infertile patients with 45X/46XY mosaicism and structural rearrangements of chromosome Y present with different phenotypes (2012) (0)
Adrenocortical carcinoma (ACC): our experience (2010) (0)
Application of Diagnostic Techniques to Endocrinology. (2015) (0)
[Various physiopathologic aspects of obesity]. (1984) (0)
Diabetes : Modern Times. (2015) (0)
Subject Index, Vol. 39, 1993 (1993) (0)
Involvement of the Endocannabinoid System in Metabolism and Fertility (2007) (0)
AMH and INSL3 levels in ovulatory and anovulatory women with the polycystic ovary syndrome (2012) (0)
Diabetes : Modern Times. (2015) (0)
Simultaneous steroid measurement by isotopic dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS): comparison with routine analysis methods and reference intervals in normal subjects (2010) (0)
Obezite ve infertilite (2008) (0)
Medical philately. Diabetes: modern times. (2010) (0)
Long-term effect of flutamide, metformin and their combination in dieting obese women with polycystic ovary syndrome (2006) (0)
Mortality in long-term follow-up patients with progressively increased patterns of subclinical cortisol hypersecretion (2013) (0)
Hirsutism and Virilization (2014) (0)
The time course of second generation antipsychotic metabolic side effects: results from a one-year prospective evaluation in a community mental health service (2007) (0)
Efficacy of two different L -thyroxine formulations in dyspeptic patients with subclinical hypothyroidism (2015) (0)
Dietary habits and body weight in an unselected population of Italian high-school students (2012) (0)
Serum Vitamin D status in women with the polycystic ovary syndrome (2017) (0)
CALORIE SUPPLEMENTATION AND CROHN'S DISEASE (1983) (0)
Prevalence and characterization of metabolic syndrome (MS) in different classes of obesity and related endocrine factors (2008) (0)
Effect of starvation treatment for obesity on the PHA response of T-lymphocytes. (1990) (0)
Front & Back Matter (2020) (0)
1 Review The impact of obesity on hyperandrogen ism and polycystic ovary syndrome in premenopausal (1993) (0)
Medical philately. Diabetes: modern times. (2010) (0)
Thyroid: From Hellenistic Greece to Renaissance. (2015) (0)
The selective neuronal deletion of cannabinoid type 1 receptor is still able to provide resistance to diet-induced obesity (2007) (0)
The GEMINUS Galileo Service Definition (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Renato Pasquali?

Renato Pasquali is affiliated with the following schools:

University of Bologna